Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban in Addition to DAPT for ACS (VaLiDate-R)
NCT03775746Phase 4Unknown
- Sponsor
- East and North Hertfordshire NHS Trust
- Start
- Jan 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rivaroxaban in acute coronary syndrome (ACS), sponsored by East and North Hertfordshire NHS Trust. Status: unknown.
02
Drugs
rivaroxaban
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT03775746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03775746.